Anixa Biosciences Inc. (ANIX)
NASDAQ: ANIX
· Real-Time Price · USD
3.64
-0.11 (-2.93%)
At close: Jun 17, 2025, 3:02 PM
Anixa Biosciences Revenue Breakdown
| Period Ending | Oct 31, 2019 |
|---|---|
| Patent Licensing Revenue | 250K |
| Patent Licensing Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Oct 31, 2012 |
|---|---|
| Taiwan Revenue | 940.01K |
| Taiwan Revenue Growth | n/a |
| United States Revenue | 4.28K |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.83M | 1.69M | 1.67M | 1.81M | 2.25M | 1.44M | 1.76M | 1.61M | 1.49M | 1.92M | 1.35M | 1.85M | 2.04M | 1.9M | 2.22M | 1.42M | 1.53M | 584.03K | 1.58M | 1.44M | 1.14M | 1.26M | 1.06M | 1.28M | 2.07M | 2.31M | 2.7M | 908.77K | 990.04K | 1.34M | 1.51M | 699.35K | 859.88K | -596.46K | 923.29K | 1.05M | 1.33M | 1.07M | 1.42M | 1.96M | 1.77M |
| Selling, General, and Administrative Revenue Growth | +8.71% | +1.20% | -7.85% | -19.49% | +56.48% | -18.22% | +9.00% | +8.27% | -22.66% | +42.31% | -27.08% | -9.21% | +7.26% | -14.31% | +56.99% | -7.69% | +162.48% | -62.96% | +9.39% | +26.51% | -9.40% | +18.97% | -17.55% | -37.96% | -10.51% | -14.59% | +197.52% | -8.21% | -26.31% | -10.89% | +115.58% | -18.67% | -244.16% | -164.60% | -12.20% | -21.02% | +24.04% | -24.56% | -27.27% | +10.31% | n/a |
| Research and Development Revenue | 1.55M | 1.48M | 1.93M | 1.65M | 1.35M | 1.61M | 1.09M | 998K | 1.07M | 1.69M | 1.45M | 1.74M | 1.84M | 2.17M | 2.17M | 1.02M | 827.65K | 1.66M | 859.29K | 1.23M | 1.49M | 871.19K | 1.09M | 1.27M | 2.25M | 2.43M | 2.94M | 660.19K | 777.87K | 351.83K | 362.97K | 431.12K | 451.63K | 413.49K | 292.06K | 392.59K | 458.05K | 711.39K | n/a | n/a | n/a |
| Research and Development Revenue Growth | +5.15% | -23.32% | +16.95% | +22.02% | -16.47% | +48.44% | +9.02% | -6.55% | -36.62% | +16.61% | -16.71% | -5.60% | -15.43% | +0.31% | +111.96% | +23.50% | -50.09% | +92.97% | -30.07% | -17.56% | +71.10% | -19.75% | -14.48% | -43.51% | -7.63% | -17.31% | +345.64% | -15.13% | +121.09% | -3.07% | -15.81% | -4.54% | +9.22% | +41.57% | -25.61% | -14.29% | -35.61% | n/a | n/a | n/a | n/a |